The Valley Desk

ArticleMolecular therapy. OncologyPublished

Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Article
Venue
Molecular therapy. Oncology
Published
Subject terms
Medulloblastoma; Neuronal differentiation; Triiodothyronine; Differentiation therapy; Combined treatment; Cytotoxic Drugs; Drug Repurposing; Chemotherapy Resistance; Tumor Relapse; Tumor Regrowth
PubMed ID
42256204
PubMed Central ID
PMC13233753
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal